SLC5A2 and type 2 diabetes mellitus: As a result, the mechanism of action of SGLT2 inhibitors includes not only glycemic control by inhibiting glucose reabsorption in the kidneys but may also bring additional health benefits, such as weight reduction, lower blood pressure, and reduced accumulation of visceral fat, making them promising drugs in the treatment of T2DM and its complications [51].